MedTrace Logo

Executive Functioning and Sleep Fragmentation in COVID-19 Patients

NCT05764096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2024-03-22

No results posted yet for this study

Summary

This project aims to investigate executive functioning abilities (primary outcome) and quality of sleep (secondary outcome) in patients with COVID-19 (while distinguishing between those with and without sleep fragmentation), compared with an age- and education matched control group of healthy individuals who did not experience contagion. Prefrontal electrical activity will be recorded with EEG in patients, and related to sleep and cognitive-executive metrics.

The main questions it aims to answer are:

* is executive functioning impaired in COVID-19 patients compared with individuals who were not infected?
* is there a relationship between altered sleep and impaired executive functioning in COVID-19 patients?
* is such relationship related to altered prefrontal brain activitity in COVID-19 patients?

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Istituto Universitario di Studi Superiori Pavia

    collaborator OTHER

  • Istituti Clinici Scientifici Maugeri SpA

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-12
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05764096 on ClinicalTrials.gov